As Robert F. Kennedy Jr. settles into his role as President Donald Trump’s health secretary, one major promise he’s made is ...

But if we can’t ban pharmaceutical ads, we can at least rein them in. Policymakers can play an integral role in addressing the manipulative advertising practices rampant in the industry, while still ...

Legal challenges to mifepristone raise questions for medical marketers about what implications this holds for the future of advertising drugs and products connected to women’s reproductive health.

Combining statins with another drug, ezetimibe, significantly reduces the risk of death in patients with clogged arteries, ...

WASHINGTON (AP) — The latest trend in treating hair loss may sound familiar — essentially, it's a repurposed drug first ...

A European regulatory committee has rejected Eli Lilly’s U.S.-approved ...